The Innovative Health Initiative (IHI) is launching its first calls for proposal in late June and it is time to start thinking about building partnerships at our kick-off and brokerage event. This one-day hybrid event will take place on 14 June 2022 at Hotel Le Plaza Brussels, where creating project proposals and building strong, effective consortia are at the core of the day. We aim to provide pertinent information; allow open and honest discussion as well as network building through face-to-face and virtual meetings.
In the first session, IHI will present the content of the calls and outline the rules for participation. Topics covered will be the research priorities of IHI, call conditions, and even specific opportunities for SMEs.
The second session is the moment for consortia building. In the room, there will be available timeslots to make short elevator pitches on your proposals.
Whether you are in the room or in a virtual environment, you will be able to book meetings through an online platform with representatives who have an interest in the same topics. This is a great opportunity to have face-to-face or virtual project idea discussions and to find partners to build a strong consortium.
There will be coffee breaks and lots of time for questions and answers to get you rolling before the dedicated networking sessions.
Participation in the event will be free of charge! However, registration and profile activation will be mandatory to attend the brokerage event. A networking lunch will be provided for those in the room.
Algal Omega-3 is an innovative feed product for aquaculture. It reduces the impact on climate change by 30-40% compared to fish oil and saves 60 tons of wild fish for every ton of Algal Omega-3 used.
Cheese is a vegetarian product thanks to biotechnology. Biotechnology is also essential to produce lactose- or cholesterol-free cheese, as well as alternative proteins.
Clothes made from alternative fibres produced by microorganisms can be 8x stronger than steel, 100% recyclable, biodegradable and replace fossil-fuel based or resource-intensive textiles.
The biomanufacturing of Vitamin B2 led to the reduction of 75% of fossil raw materials and 50% operating costs, compared to the chemical process. Vitamin B2 is used in the food, feed or healthcare sectors.
Enzymes and biosurfactancts are alternative ingredients that improve the performance of detergents, while leading to water and energy savings and reductions in CO2 emissions and water toxicity.
Insulin is one of the most widely known biopharmaceutical. Biotechnology revolutionised its manufacturing process and led to the development of new types of insulin through r-DNA technology.